Abbott (NYSE: ABT) CFO adds 2,200 shares in open-market buy

Rhea-AI Filing Summary

Abbott Laboratories EVP and CFO Philip P. Boudreau reported multiple common share holdings and transactions dated April 23, 2026. A key event was an open-market purchase of 2,200 common shares at $91.50 per share, held indirectly through his spouse.

The filing also shows a discretionary transaction under Rule 16b-3(f) involving 8,909 common shares at $92.04 per share in a profit sharing trust, bringing that trust’s balance to 9,276 shares as of that date. Separately, Boudreau reports 71,172 common shares held directly after these transactions.

Insider Trade Summary

Net Buyer: 2,200 shares ($201,300)

Net Buy 3 txns

Insider Boudreau Philip P

Role EVP AND CFO

Bought 2,200 shs ($201K)

Type	Security	Shares	Price	Value
I	Common shares without par value	8,909	$92.04	$820K
Purchase	Common shares without par value	2,200	$91.50	$201K
holding	Common shares without par value	--	--	--

Holdings After Transaction: Common shares without par value — 9,276 shares (Indirect, Profit Sharing Trust); Common shares without par value — 71,172 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Open-market purchase: 2,200 shares at $91.50 Discretionary trust transaction: 8,909 shares at $92.04 Trust balance after transaction: 9,276 shares +2 more

5 metrics

Open-market purchase 2,200 shares at $91.50 Common shares bought indirectly by spouse on April 23, 2026

Discretionary trust transaction 8,909 shares at $92.04 Profit sharing trust transaction on April 23, 2026

Trust balance after transaction 9,276 shares Abbott Laboratories Stock Retirement/Profit Sharing Trust as of April 23, 2026

Direct holdings after transactions 71,172 shares Common shares held directly by Philip P. Boudreau

Indirect spouse holdings 2,200 shares Common shares held indirectly by spouse after open-market purchase

Key Terms

open-market purchase, discretionary transaction under Rule 16b-3(f), Profit Sharing Trust, Stock Retirement Trust

4 terms

open-market purchase financial

"transaction_action: "open-market purchase" for 2,200 common shares at $91.5000"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

discretionary transaction under Rule 16b-3(f) regulatory

"transaction_code_description: "Discretionary transaction under Rule 16b-3(f)""

Profit Sharing Trust financial

"nature_of_ownership: "Profit Sharing Trust" for 8,909 common shares"

Stock Retirement Trust financial

"footnote: "Balance in the Abbott Laboratories Stock Retirement Trust as of April 23, 2026.""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boudreau Philip P

(Last) (First) (Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK ILLINOIS 60064

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP AND CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common shares without par value	04/23/2026		I		8,909	A	$92.04	9,276(1)	I	Profit Sharing Trust
Common shares without par value	04/23/2026		P		2,200	A	$91.5	2,200	I	By Spouse
Common shares without par value								71,172	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Balance in the Abbott Laboratories Stock Retirement Trust as of April 23, 2026.

	/s/ Philip P. Boudreau by Jessica H. Paik, Attorney-in-Fact	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider share purchase did Abbott Laboratories (ABT) report for Philip P. Boudreau?

Abbott Laboratories reported that EVP and CFO Philip P. Boudreau was associated with an open-market purchase of 2,200 common shares at $91.50 per share. These shares are held indirectly through his spouse, reflecting additional personal exposure to Abbott stock.

How many Abbott (ABT) shares does Philip P. Boudreau hold directly after this Form 4?

After the reported transactions, Philip P. Boudreau holds 71,172 Abbott common shares directly. This figure represents his direct ownership, separate from additional indirect holdings reported through his spouse and a profit sharing trust associated with Abbott stock.

What was the profit sharing trust transaction in Abbott (ABT) stock on April 23, 2026?

The Form 4 shows a discretionary transaction involving 8,909 Abbott common shares at $92.04 per share in a profit sharing trust. Following this transaction, the trust’s balance is reported as 9,276 shares as of April 23, 2026.

How are Philip P. Boudreau’s indirect Abbott (ABT) holdings structured?

Boudreau’s indirect holdings include 2,200 Abbott common shares held by his spouse following an open-market purchase, and 9,276 shares held in a profit sharing trust. These indirect positions complement his separate direct ownership of 71,172 shares.

Does this Abbott (ABT) Form 4 show any insider sales by Philip P. Boudreau?

The transaction summary indicates a net buy position of 2,200 shares and no reported open-market sales. Activity includes one open-market purchase and a discretionary profit sharing trust transaction, alongside an updated direct holding line showing 71,172 common shares.